Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal < em > in situ < /em > gel: formulation and characterization

Conclusion: The utilization of an intranasal cubosomal in situ gel encapsulated with TCA was anticipated to lower intracranial pressure and improve patient adherence by offering effective relief for individuals suffering from Brain edema. This efficacy is attributed to its rapid onset of action and its safe and well-tolerated dosage form.PMID:38148515 | DOI:10.1080/03639045.2023.2297275
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Authors: Source Type: research